Oragenics (OGEN) FCF Margin (QoQ) (2010 - 2023)
Oragenics (OGEN) FCF Margin (QoQ) (2010 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Oragenics | 2.31 Mn | 2.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -55,664.00 |
| Jun 30, 2023 | -718,818.00 |
| Sep 30, 2022 | 669,973.00 |
| Jun 30, 2022 | 2.68 Mn |
| Dec 31, 2014 | -2,973.00 |
| Sep 30, 2014 | 1,163.00 |
| Jun 30, 2014 | 18,839.00 |
| Mar 31, 2014 | -46,611.00 |
| Dec 31, 2013 | 49,890.00 |
| Sep 30, 2013 | 41,336.00 |
| Jun 30, 2013 | -29,681.00 |
| Mar 31, 2013 | -49,186.00 |
| Dec 31, 2012 | 4,148.00 |
| Sep 30, 2012 | 268.00 |
| Jun 30, 2012 | -14,806.00 |
| Mar 31, 2012 | 5,041.00 |
| Dec 31, 2011 | 8,269.00 |
| Sep 30, 2011 | -1,312.00 |
| Jun 30, 2011 | -9,929.00 |
| Mar 31, 2011 | 24,903.00 |